NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/30/2025
Back to search
Official data from USPTO
COMPASSIONATE SAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
COMPASSIONATE SAGE
ST13
US500000087488853Class
5, 30, 32, 35
Filing
87488853
Registration
5683083
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
05/31/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 30, 32, 35
Filing date
06/14/2017
Registration date
02/26/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2021
Last transaction
05/31/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Tai Po, NT, HK
Examiner
DESAI, BRIN ANDERSON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Purapharm International (H.K.) Limited
Purapharm International (H.K.) Limited
Representatives
Haverly MacArthur Adams and Reese LLP
Technical classification
Nice Classes
Class 5Class 30Class 32Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Health preparations for medical purposes for strengthening the immune system and restoring normal bodily functionsthe treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorderscentral nervous system diseases and disordersbrain diseasesmovement disordersocular motilityrespiratory diseases and disordersexcretory diseases and disorderscardiovascular diseases and disordersreproductive diseases and disordersendocrinal diseases and disordersimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitisdermatological diseases and disordersskeletal diseases and disordersbone diseasesback painmuscular diseases and disordersmuscular dystrophyinflammatory muscle diseasessensory diseases and disordersblindness; medicines for human purposes for strengthening the immune system and restoring normal bodily functionsthe treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorderscentral nervous system diseases and disordersbrain diseasesmovement disordersocular motilityrespiratory diseases and disordersexcretory diseases and disorderscardiovascular diseases and disordersreproductive diseases and disordersendocrinal diseases and disordersimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitisdermatological diseases and disordersskeletal diseases and disordersbone diseasesback painmuscular diseases and disordersmuscular dystrophyinflammatory muscle diseasessensory diseases and disordersblindness; medicines for veterinary purposes for strengthening the immune system and restoring normal bodily functionsthe treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorderscentral nervous system diseases and disordersbrain diseasesmovement disordersocular motilityrespiratory diseases and disordersexcretory diseases and disorderscardiovascular diseases and disordersreproductive diseases and disordersendocrinal diseases and disordersimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitisdermatological diseases and disordersskeletal diseases and disordersbone diseasesback painmuscular diseases and disordersmuscular dystrophyinflammatory muscle diseasessensory diseases and disordersblindness; medicines for dental purposes; medicinal herbs; medicinesincluding Chinese medicines and Chinese patent medicinesfor strengthening the immune system and restoring normal bodily functionsthe treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorderscentral nervous system diseases and disordersbrain diseasesmovement disordersocular motilityrespiratory diseases and disordersexcretory diseases and disorderscardiovascular diseases and disordersreproductive diseases and disordersendocrinal diseases and disordersimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitisdermatological diseases and disordersskeletal diseases and disordersbone diseasesback painmuscular diseases and disordersmuscular dystrophyinflammatory muscle diseasessensory diseases and disordersblindness; medical infusionsmedicinal herbal infusions; herbal food supplements adapted for medical use; herbal food supplements; pharmaceuticalsmedical and veterinary preparations for strengthening the immune system and restoring normal bodily functionsthe treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorderscentral nervous system diseases and disordersbrain diseasesmovement disordersocular motilityrespiratory diseases and disordersexcretory diseases and disorderscardiovascular diseases and disordersreproductive diseases and disordersendocrinal diseases and disordersimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitisdermatological diseases and disordersskeletal diseases and disordersbone diseasesback painmuscular diseases and disordersmuscular dystrophyinflammatory muscle diseasessensory diseases and disordersblindness; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary usefood for babies; dietary supplements for humans ; and animals; plasters for medical purposes; materials for medical dressingsgauze and bandages; material for stopping teethdental wax; disinfectants ; preparations for destroying vermin; fungicidesherbicides
Class 30
Processed herbs; herbal infusionsnot adapted for medical use ; tea-based beverages; coffeeteacocoa and artificial coffee; rice; tapioca and sago; flour; preparations made from cerealscereal-based snack foods and cereal bars; breadpastries and confectionery in the nature of confectionery made of sugar; edible ices; sugarhoneytreacle; yeastbaking-powder; salt; mustard; vinegarsauces; spices; ice
Class 32
Non-alcoholic beveragesnon-alcoholic beverages with tea flavor; preparations for making beveragesfruit drinks and non-alcoholic beverages; essences for making beverages not in the nature of essential oilsessences for making soft drinks and non-alcoholic beverages ; beers; mineral and aerated waters; fruit-based beverages and fruit juices; syrups for making tea
Class 35
Mediation of agreements for the purchase and sale of health preparations for medical purposesmedicines for human purposesmedicines for veterinary purposesmedicines for dental purposesmedicinal herbsmedicinesincluding Chinese medicines and Chinese patent medicinesherbal food supplementsboth for medical and non-medical useherbsinfusions for both medical and non-medical useincluding those in the context of wholesaling; retail store services in the field of herbs and herb-related goods; retail and wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; online and physical shop retail and wholesale store services in the field of health preparations for medical purposes; advertising; business management; business administration; office functions
Publications
History of USPTO decisions and trademark events.
49 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
12/30/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/15/2025
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
06/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2025
ES8R
TEAS SECTION 8 RECEIVED
02/26/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
07/13/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/28/2021
CANT
CANCELLATION TERMINATED NO. 999999
10/28/2021
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
10/28/2021
CANG
CANCELLATION GRANTED NO. 999999
10/27/2021
PETC
CANCELLATION INSTITUTED NO. 999999
08/19/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2018
PUBO
PUBLISHED FOR OPPOSITION
12/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/21/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/26/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/18/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/05/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/05/2018
CNSI
SUSPENSION INQUIRY WRITTEN
07/05/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/02/2018
GNSL
LETTER OF SUSPENSION E-MAILED
01/02/2018
CNSL
SUSPENSION LETTER WRITTEN
01/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2017
ALIE
ASSIGNED TO LIE
12/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/17/2017
GPRA
PRIORITY ACTION E-MAILED
08/17/2017
CPRA
PRIORITY ACTION WRITTEN
08/17/2017
DOCK
ASSIGNED TO EXAMINER
08/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2017
NWAP
NEW APPLICATION ENTERED
06/17/2017
Continuous trademark protection
Get notified about every new filing that threatens COMPASSIONATE SAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.